Anti-CRMP2 (phospho T514) antibody
| Name | Anti-CRMP2 (phospho T514) antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab62478 |
| Prices | $390.00 |
| Sizes | 100 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA ICC/IF ICC/IF IHC-P WB |
| Species Reactivities | Mouse, Rat, Human |
| Antigen | Synthetic phosphopeptide derived from human CRMP2 around the phosphorylation site of threonine 514 (T-V-TP-P-A) |
| Description | Rabbit Polyclonal |
| Gene | DPYSL2 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab62478, at 1/50 dilution, staining CRMP2 in paraffin embedded human brain tissue by Immunohistochemsitry in the absence (left image) or presence (right image) of the immunising peptide.
ab62478, at 1/500 dilution, staining CRMP2 in HeLa cells by Immunofluorescence, in the absence or presence of the immunising peptide.
Anti-CRMP2 (phospho T514) antibody (ab62478) at 1 µg/ml + Brain (Human) Tissue Lysate - adult normal tissue (ab29466) at 10 µgSecondaryGoat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Immunofluorescence analysis of RPE cells, staining CRMP2 (phospho T514) with ab62478. Cells were fixed in cold methanol and incubated with primary antibody, followed by an AlexaFluor®488-conjugated anti rabbit IgG.
Product References
Localized changes to glycogen synthase kinase-3 and collapsin response mediator - Localized changes to glycogen synthase kinase-3 and collapsin response mediator
Lim NK, Hung LW, Pang TY, Mclean CA, Liddell JR, Hilton JB, Li QX, White AR, Hannan AJ, Crouch PJ. Hum Mol Genet. 2014 Aug 1;23(15):4051-63.
Interleukin-18 alters protein expressions of neurodegenerative diseases-linked - Interleukin-18 alters protein expressions of neurodegenerative diseases-linked
Sutinen EM, Korolainen MA, Hayrinen J, Alafuzoff I, Petratos S, Salminen A, Soininen H, Pirttila T, Ojala JO. Front Cell Neurosci. 2014 Aug 7;8:214.
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. - PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.
Jun G, Asai H, Zeldich E, Drapeau E, Chen C, Chung J, Park JH, Kim S, Haroutunian V, Foroud T, Kuwano R, Haines JL, Pericak-Vance MA, Schellenberg GD, Lunetta KL, Kim JW, Buxbaum JD, Mayeux R, Ikezu T, Abraham CR, Farrer LA. Ann Neurol. 2014 Sep;76(3):379-92.
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate - Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate
Oliemuller E, Pelaez R, Garasa S, Pajares MJ, Agorreta J, Pio R, Montuenga LM, Teijeira A, Llanos S, Rouzaut A. Int J Cancer. 2013 May 1;132(9):1986-95.
Targeting of CRMP-2 to the primary cilium is modulated by GSK-3beta. - Targeting of CRMP-2 to the primary cilium is modulated by GSK-3beta.
Ou Y, Zhang Y, Cheng M, Rattner JB, Dobrinski I, van der Hoorn FA. PLoS One. 2012;7(11):e48773.
Hypoxia-ischemia induces hypo-phosphorylation of collapsin response mediator - Hypoxia-ischemia induces hypo-phosphorylation of collapsin response mediator
Sato Y, Ishida-Nakajima W, Kawamura M, Miura S, Oguma R, Arai H, Takahashi T. Brain Res. 2011 Apr 22;1386:165-74.